申请人:Pfizer Inc.
公开号:US04694080A1
公开(公告)日:1987-09-15
Certain substituted-4-hydroxy-(or 4-acyloxy-)2H-1,2-benzothiazine 1,1-dioxides having at the 3-position a 2-substituted-1,3,4-oxadiazol-5-yl, a 2-substituted-tetrazol-5-yl or a 1-substituted-tetrazol-5-yl group useful as selective 5-lipoxygenase pathway inhibitors; and methods for their preparation.
具有在3位的2-取代-1,3,4-噁二唑-5-基、2-取代-四氮唑-5-基或1-取代-四氮唑-5-基的某些取代-4-羟基-(或4-酰氧基)-2H-1,2-苯并噻嗪-1,1-二氧化物,可用作选择性5-脂氧合酶途径抑制剂;以及它们的制备方法。